Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Nutrients|April 12, 2022
Nutrition Intervention and Cardiovascular DiseaseMaria Pia Adorni, Nicola Ferri
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Drug-drug interactions in polypharmacy patients: The impact of renal impairmentBianca Papotti, Cinzia Marchi, Maria Pia Adorni, et al.
Atherosclerosis Plus|January 29, 2025
Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: Focus on PPARs, LXRs, and PCSK9Marcella Palumbo, Martina Ugolotti, Francesca Zimetti, et al.
Journal of Cardiovascular Pharmacology|June 25, 2013
Rac1 and cholesterol metabolism in macrophageMaria Pia Adorni, Nicoletta Ronda, Franco Bernini, et al.
Cells|April 3, 2021
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological PerspectivesMaria Pia Adorni, Nicoletta Ronda, Franco Bernini, et al.
Frontiers in Aging Neuroscience|June 11, 2019
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's DiseaseMaria Pia Adorni, Massimiliano Ruscica, Nicola Ferri, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 13, 2022
Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disordersMarta Turri, Cinzia Marchi, Maria Pia Adorni, et al.
Nutrients|May 21, 2020
Naturally Occurring PCSK9 InhibitorsMaria Pia Adorni, Francesca Zimetti, Maria Giovanna Lupo, et al.
Antioxidants (Basel, Switzerland)|December 8, 2020
HDL Proteome and Alzheimer's Disease: Evidence of a LinkJudit Marsillach, Maria Pia Adorni, Francesca Zimetti, et al.
Handbook of Experimental Pharmacology|December 20, 2014
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and functionMonica Gomaraschi, Maria Pia Adorni, Maciej Banach, et al.
Pageof 7